Member Info for FunnyGuy

Interesting that end of feb seems to be talked about. Do you think that is realistic or is there any need for an RNS by end of Feb?

Hopefully they staff are workign tirelessly to do a deal and maximise shareholder value, whihc as a listed company is its objective

Time will tell Sad and its mid february, they need to deliver

You literally asked people to estimate, i did that and said 25p max. i will stick with that

I do sad, i reckon about 25p maximum, as any reporting without news of commercial advance will not improve the price much at all, and you know that

You think its time to buy? I have 8k coming next week, perhaps i will buy some more. On a different note, anyone have issues with Swissquote specifically with having to do KYC

Why the price drop?

Its February so i think its a very important month and so does Sad

Celtic have always been poor on communications. So to fill the vacuum there is lots of conjecture on this board and most of it is so wide of the mark. It usually the "positive" people who are so wide of the mark with take overs, 10-pound valuations, best in class stuff. However, Sareum always manage to disappoint, or they have done over the last few years commercially. This is why the share price is drifting. 10p does seem low but i would wager more likely currently than 3-4 pound. Makes no difference to me. I am not buying more or selling. I have 53,000 shares so it will pay off but i dont dream of being a multi millionaire either. I dont care what anyone says, the handling of this by SAR since the original RNS has been really poor and i would be surprised if there is a negative shock to happen in Feb

There goes bad cop again.

watch the football

Sad i don't know who you work for either a broker or sareum or a bio magazine, but you are always positive, but you are forever stretching it out with your posts. First you were expecting things in December, recently you were suggesting Feb, now your post is moving it on a whole qtr. To date, you have written alot of detail but i feel not one you have posted has read correct about the company we have invested in ie Sareum which is dragging its feet while other companies' news and witnessing share price increases. Then you have your friend Celtic backing you up like good cop back cop.

What is a USA

SAD- i will hold you to end of Feb if thats ok. then if no positive news i think you need to re assess

I have not seen it where you have posted about 737 valuations, so i stand corrected and apologies about that.

Off topic i have also been trading a bit while SAR is dormant. Quantum computing companies US has paid for more Christmas and a few trips so that's been really good. I am back in again , really as i was caught out a bit the other week so i decided to take advantage of the big drop.

QMCO has been very good to me

Hi Sad

as you are probably the most confident about SAR prospects, could you tell me what would need to happen for you to have concerns. For example if we reach end of Feb and still no update would that concern you ?

Its irrelevant pretty much. MBJ is full of articles and any of these can be lifted. This is not about the company Sareum. Sometime you just need to look at the performance of the company as a company. It currently has lost 90% of shareholder value in a few years.

Sad

what are you saying because you seem to write a lot! you are different eulogizing about sra737 and given it a 800 million valuation now you are saying it could be dead but probably not dead. Then you bamboozle everything with incredidly long messages which lots of time do not mean too much to the average investor of SAR and I'm not convinced that they mean much to you. Do you work in pharma or are you just an investor who likes pharma industry? Or are you working for a broker? When i mentioned Sareum taking control, i do mean that the somehow negotiate enough ownership to take it beyond 50%. That does not necessarily mean capital purchase by cash but it coulkd be by negotiation. SRA737 is dead as afar as im concerned. 1 super big pharma dropped, 2 small pharma have also dropped or not proceeded. if it is not strategically important to us why put a huge value on it. It should be discounted fully as i would suggest the small drop in share price indicates. So this leads to more relevant stuff. It was rns that by end of dec we would have more information and we have not , sareum have not kept to their word.

Please can everyone drop the talk about SRA737. I t has been kicked around, dropped twice 2nd time with no payment .It is as the Monty Python sketch goes a dead parrot and its disingenuous to keep talking it out. The company should be judged on something it controls rather than a share in something it cant control. If it was useful we would have taken control of it.

Still waiting on the data they promised

Bailiff

i really hope it works out for you, it's a massive investment but you could be in for upwards from 3m which would be lovely

108K Bailiff

are your sure you are telling the truth there?

All this good news and SAR lost 50% of its value this year. Hopefully they recoup that & some in 2025!

At some stage the talk has to be less about the science and more about commercialisation. Having said that a license would easily gives us a 50% rise